Amos Pasternack - Publications, H-index & Citations

Amos Pasternack

Tampere University

53H指数

382论文数

1.3W被引数

收录论文 36

发表时间

Undergraduate studies in psychiatry in the problem-based learning medical curriculum at University of Tampere

EUROPEAN PSYCHIATRY

IF6.7

2020-04-16

OAAI

Kaltiala-Heino, R; Pasternack, A

The level of autoantibodies against oxidized LDL is not associated with the presence of coronary heart disease or diabetic kidney disease in patients with non-insulin-dependent diabetes mellitus

FREE RADICAL RESEARCH

IF2.9

2015-05-21

PREAI

Leinonen, JS; Rantalaiho, V; Laippala, P; Wirta, O; Pasternack, A; Alho, H; Jaakkola, O; Ylä-Herttuala, S; Koivula, T; Lehtimäki, T

Serum N-terminal atrial natriuretic peptide in adult patients late after surgical repair of atrial septal defect

EUROPEAN JOURNAL OF HEART FAILURE

IF10.8

2012-04-17

OAAI

Iivainen, TE; Groundstroem, KWE; Lahtela, JT; Talvensaari, TJ; Pasternack, A; Uusitalo, A

Physicians' Ethics Forum: a web-based ethics consultation service

JOURNAL OF MEDICAL ETHICS

IF3.4

2011-06-29

PREAI

Louhiala, Pekka; Saarni, Samuli; Hietala, Katri; Pasternack, Amos

ALBUMIN EXCRETION RATE AND ITS RELATION TO KIDNEY-DISEASE IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS

JOURNAL OF INTERNAL MEDICINE

IF9.2

2009-08-04

PREAI

WIRTA, O; PASTERNACK, A; MUSTONEN, J; OKSA, H; KOIVULA, T; HELIN, H

The association between the total antioxidant potential of plasma and the presence of coronary heart disease and renal dysfunction in patients with NIDDM

FREE RADICAL RESEARCH

IF2.9

2009-07-07

PREAI

Leinonen, J; Rantalaiho, V; Lehtimäki, T; Koivula, T; Wirta, O; Pasternack, A; Alho, H

Severity of tubulointerstitial inflammation and prognosis in immunoglobulin A nephropathy

KIDNEY INTERNATIONAL

IF12.6

2007-02-01

OAAI

Myllymaki, J. M.; Honkanen, T. T.; Syrjanen, J. T.; Helin, H. J.; Rantala, I. S.; Pasternack, A. I.; Mustonen, J. T.

Mutation C677T of methylenetetrahydrofolate reductase gene is not associated with coronary artery disease, but possibly with albuminuria, in type 2 diabetic patients

CLINICAL CHEMISTRY AND LABORATORY MEDICINE

IF3.7

2005-06-01

PREAI

Wirta, V; Huang, XH; Wirta, O; Rantalaiho, V; Pasternack, A; Jokela, H; Koivula, T; Lehtimaki, T

R643G polymorphism in PECAM-1 influences transendothelial migration of monocytes and is associated with progression of CHD and CHD events

ATHEROSCLEROSIS

IF5.7

2004-11-01

PREAI

Elrayess, MA; Webb, KE; Bellingan, GJ; Whittall, RA; Kabir, J; Hawe, E; Syvänne, M; Taskinen, MR; Frick, MH; Nieminen, MS; Kesäniemi, YA; Pasternack, A; Miller, GJ; Humphries, SE

Urinary excretion of interleukin-6 correlates with proteinuria in acute Puumala Hantavirus-induced nephritis

AMERICAN JOURNAL OF KIDNEY DISEASES

IF8.2

2004-05-01

PREAI

Mäkelä, S; Mustonen, J; Ala-Houhala, I; Hurme, M; Koivisto, AM; Vaheri, A; Pasternack, A

APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease:: results from the LOCAT study

JOURNAL OF LIPID RESEARCH

IF4.1

2004-04-01

109

OAAI

Talmud, PJ; Martin, S; Taskinen, MR; Frick, MH; Nieminen, MS; Kesäniemi, YA; Pasternack, A; Humphries, SE; Syvänne, M

Cost analysis of renal replacement therapies in Finland 芬兰中肾脏替代治疗的成本分析

AMERICAN JOURNAL OF KIDNEY DISEASES

IF8.2

2003-12-01

PREAI

Salonen, T; Reina, T; Oksa, H; Sintonen, H; Pasternack, A

A novel functional polymorphism in the PECAM-1 gene (53G>A) is associated with progression of atherosclerosis in the LOCAT and REGRESS studies

ATHEROSCLEROSIS

IF5.7

2003-05-01

PREAI

Elrayess, MA; Webb, KE; Flavell, DM; Syvänne, M; Taskinen, MR; Frick, MH; Nieminen, MS; Kesäniemi, YA; Pasternack, A; Jukema, JW; Kastelein, JJP; Zwinderman, AH; Humphries, SE

Progression of atherosclerosis is associated with variation in the α1-antitrypsin gene

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

IF7.4

2003-04-01

PREAI

Talmud, PJ; Martin, S; Steiner, G; Flavell, DM; Whitehouse, DB; Nagl, S; Jackson, R; Taskinen, MR; Frick, MH; Nieminen, MS; Kesäniemi, YA; Pasternack, A; Humphries, SE; Syvänne, M

Plasma concentrations of asymmetric-dimethyl-arginine in type 2 diabetes associate with glycemic control and glomerular filtration rate but not with risk factors of vasculopathy

METABOLISM-CLINICAL AND EXPERIMENTAL

IF11.9

2003-03-01

PREAI

Päivä, H; Lehtimäki, T; Laakso, J; Ruokonen, I; Rantalaiho, V; Wirta, O; Pasternack, A; Laaksonen, R

IgM nephropathy:: Clinical picture and long-term prognosis

AMERICAN JOURNAL OF KIDNEY DISEASES

IF8.2

2003-02-01

PREAI

Myllymäki, J; Saha, H; Mustonen, J; Helin, H; Pasternack, A

Apolipoprotein E gone polymorphism, hypercholesterolemia and glomerular filtration rate in type 2 diabetic subjects:: A 9-year follow-up study

JOURNAL OF BIOMEDICAL SCIENCE

IF12.1

2003-01-01

PREAI

Lehtinen, S; Rantalaiho, V; Wirta, O; Pasternack, A; Laippala, P; Koivula, T; Lehtimäki, T

Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-α(-308) G/A polymorphism

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2002-09-15

PREAI

Mäkelä, S; Mustonen, J; Ala-Houhala, I; Hurme, M; Partanen, J; Vapalahti, O; Vaheri, A; Pasternack, A

Peroxisome proliferator-activated receptor α gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease

CIRCULATION

IF38.6

2002-03-26

136

PREAI

Flavell, DM; Jamshidi, Y; Hawe, E; Torra, LP; Taskinen, MR; Frick, MH; Nieminen, MS; Kesäniemi, YA; Pasternack, A; Staels, B; Miller, G; Humphries, SE; Talmud, PJ; Syvänne, M

Polymorphism of the cytokine genes and IgA nephropathy 细胞因子基因多态性与IgA肾病

KIDNEY INTERNATIONAL

IF12.6

2002-03-01

OAAI

Syrjänen, J; Hurme, M; Lehtimäki, T; Mustonen, J; Pasternack, A

研究方向